A.P. Møller - Mærsk A/S
30.6.2026 14:25:50 CEST | Globenewswire | Press release
Information about changed number of votes and share capital
Information about changed number of votes and share capital
ANNOUNCEMENT
A.P. Møller - Mærsk A/S – Information about changed number of votes and share capital
At the Annual General Meeting of the Company on 25 March 2026, it was decided to decrease the Company’s share capital by cancellation of treasury shares. The capital decrease was finally completed and registered with the Danish Business Authority on 4 June 2026.
Pursuant to the Danish Capital Markets Act, section 32, the total number of voting rights and the total amount of capital in the Company as of 30 June 2026 is hereby published:
| Type | Number of shares | Number of votes | Capital |
| A shares of DKK 1,000 | 9,586,385 | 19,172,770 | DKK 9,586,385,000 |
| A shares of DKK 500 | 206 | 206 | DKK 103,000 |
| B shares of DKK 1,000 | 5,109,279 | N/A | DKK 5,109,279,000 |
| B shares of DKK 500 | 122 | N/A | DKK 61,000 |
| Total share capital | DKK 14,695,828,000 |
Copenhagen, 30 June 2026
Contact person: Head of Investor Relations, Martin Dunwoodie, tel. +45 3363 3484
Page 1 of 1
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Novo Nordisk A/S15.7.2026 17:50:45 CEST | Press release
Novo Nordisk receives European Commission approval of Wegovy® pill as first oral GLP-1 for weight management in the EU; single, ready-to-use pen for higher dose 7.2 mg also approved
North Media A/S15.7.2026 15:13:58 CEST | Pressemeddelelse
Svensk pressemeddelelse fra SDR
North Media A/S15.7.2026 15:13:58 CEST | Press release
Swedish press release from SDR
Fluence15.7.2026 15:00:00 CEST | Press release
Fluence Retains Tier 1 Energy Storage Supplier Status in S&P Global Energy 2026 Cleantech List
Persephoni Bio15.7.2026 15:00:00 CEST | Press release
Persephoni Backs SelSym Biotech to Bring Blood-Type-Agnostic Bleeding Control to the Point of Injury
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom